scispace - formally typeset
W

Werner Leber

Researcher at Queen Mary University of London

Publications -  21
Citations -  274

Werner Leber is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Cluster randomised controlled trial & Population. The author has an hindex of 7, co-authored 19 publications receiving 225 citations. Previous affiliations of Werner Leber include University of London.

Papers
More filters
Journal ArticleDOI

Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection.

TL;DR: The authors studied the humoral response in 210 treatment-naïve chronically HIV-1-infected (>1 year) adult subjects against a panel of 12 viruses from six different clades and found plasmas from individuals infected with clade C were significantly more potent at neutralizing the tested viruses.
Journal ArticleDOI

Does general practice deliver safe primary care to people living with HIV? A case-notes review.

TL;DR: In a large-scale evaluation of GP records of people living with HIV, gaps in ART recording and co-prescribing were identified, and evidence demonstrated missed opportunities for diagnosis within general practice.
Journal ArticleDOI

Determining the level of social distancing necessary to avoid future COVID-19 epidemic waves: a modelling study for North East London.

TL;DR: In this paper, the authors used mathematical modelling to simulate the levels of COVID-19 in North East London (NEL) and inform the level of social distancing necessary to protect the public and the healthcare demand from future epidemic waves.
Journal ArticleDOI

Point-of-care HIV testing in primary care and early detection of HIV (RHIVA2): a cluster randomised controlled trial

TL;DR: It is shown that a programme offering rapid HIV testing at general practice registration led to earlier detection of HIV, and identified cases from non-MSM risk groups, and recommend that large-scale HIV testing be implemented in UK general practices in high-prevalence settings.